MDSpire - MDSpire Home

MDSpire - MDSpire Home

Region

United States US publications and network International Global sites and content

The premier global destination for healthcare professionals looking for trusted clinical content, breaking news, and a wealth of educational resources.

Conexiant.com
Conexiant Education

Trusted by leading healthcare organizations to deliver measurable engagement, education, and brand growth.

Conexiant Solutions
Conexiant DXP

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

MDSpire.com
DentalSpire.com

Association Partner

Our vision is a world free from digestive diseases. That's why it's our mission to empower clinicians and researchers to improve digestive health.

gastro.org
agau.org.gastro
myaga.gastro.org
foundation.gastro.org
agajournals.org
healthecareers.com

Conexiant.com
Conexiant Education

Conexiant DXP

MDSpire.com
DentalSpire.com

gastro.org
myaga.gastro.org
agajournals.org
agau.org.gastro
foundation.gastro.org

Advertisement

What is MDSpire?

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

Learn More

Choose specialties Cardiology Dermatology Endocrinology Family Medicine Gastroenterology Hematology Internal Medicine Neurology ObGyn Oncology Ophthalmology Optometry Pediatrics Rheumatology Pulmonary Psychiatry Pathology Surgery Orthopedic Medicine Radiology Otolaryngology Infectious Disease

May 6, 2026

Building Bridges: The Impact of Medical Science Liaison and Advanced Practice Provider Collaborations

Katherine Albert
Kristina Byers
Chelsey Boggs
May 6, 2026
11 min

Summary
Takeaways
Insight Report
Quiz
Poll
Top Institutions

Objective: To explore the collaboration between medical science liaisons (MSLs) and advanced practice providers (APPs) in enhancing cancer care through educatio

Collaboration between medical science liaisons (MSLs) and advanced practice providers (APPs) enhances cancer care through education and research.
MSLs provide tailored education and support clinical trials, enabling APPs to make informed decisions and improve patient outcomes.
The MSL role, established in 1967, has evolved to include clinical trial support and medical education, distinct from commercial sales.
MSLs operate in a non-promotional capacity, delivering unbiased, evidence-based information while adhering to compliance standards.
Effective MSL-APP partnerships focus on clinical research, medical education, and insight gathering, bridging scientific innovation and clinical application.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

May 6, 2026

Colorectal Cancer Treatment During Pregnancy

Kathryn L. Green
Rachel Hatch
May 6, 2026
17 min

Summary
Insight Report
Poll
Clinical Scorecard
Top Institutions

Objective: To discuss the complexities of diagnosing and treating colorectal cancer (CRC) in pregnant patients, emphasizing the importance of a multidisciplinar

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

May 6, 2026

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

Maria D. Guerrero
May 6, 2026
13 min

Summary
Quiz
Top Institutions

Objective: To evaluate the efficacy and safety of Nivolumab-AVD compared to BV-AVD in treating advanced-stage classical Hodgkin lymphoma (cHL). Key Findings: Ni

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

May 6, 2026

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

Mark Davis
May 6, 2026
18 min

Summary
Quiz
Top Institutions

Objective: To evaluate the impact of treatment intensity on outcomes for transplant-ineligible patients with multiple myeloma (MM), emphasizing its significance

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

May 6, 2026

Retrospective Characterization of Specialized Palliative Care in Patients With Gliomas

Sisse Josephine Rudkjøbing
Katrine Rahbek Schønnemann
Jesper Rahr Lauritsen
Bo Halle
Rikke Hedegaard Dahlrot
May 6, 2026
13 min

Summary
Quiz

Objective: To evaluate the referral patterns and characteristics of patients with gliomas receiving specialized palliative care (SPC) and assess the interdiscip

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

May 6, 2026

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals

Heather Sloan
Sarah J. Jennings
Kristi Adair
Anne Stein
May 6, 2026
24 min

Summary
Quiz
Clinical Scorecard

Objective: To evaluate the impact of distress screening on psychosocial referrals for head and neck cancer survivors. Key Findings: Rephrase findings for clarit

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Analytical Scientist

May 5, 2026

A Molecular Record of Repairs from a Roman Shipwreck

May 5, 2026
3 min

Summary
Takeaways

A recent study analyzed waterproofing residues from a 2,200-year-old Roman shipwreck near Ilovik Island, Croatia, identifying distinct coating batches that indi

The study analyzed waterproofing residues from a Roman shipwreck.
Distinct coating batches indicate successive ship repairs.
Techniques used include ATR-FTIR and GC-MS.
Pollen analysis added context about vegetation during coating application.
Four to five distinct batches were identified across the wreck.
Research highlights the importance of organic coatings in understanding ancient shipbuilding.
Findings show regional characteristics of shipbuilding in the Adriatic.

The Medicine Maker

May 5, 2026

This Week’s Biopharma News: EU Clears First Pertuzumab Biosimilar

May 5, 2026
5 min

Summary
Takeaways

The European Commission has approved POHERDY, the first biosimilar for pertuzumab, which treats HER2-positive breast cancer, affirming its efficacy and safety f

POHERDY is the first biosimilar for pertuzumab in Europe.
NICE recommends rozanolixizumab for myasthenia gravis.
GX-BP1 shows 70% tumor inhibition in preclinical models.
Ecolab opened a new bioprocessing lab in Korea.
WuXi Biologics achieved GMP certification for bispecific antibodies in Korea.

The Pathologist

May 5, 2026

Weight-loss Drug Response Varies, But Why?

May 5, 2026
2 min

Summary
Takeaways

A recent study published in Nature highlights the role of common genetic variations in predicting patient responses to GLP-1-based weight-loss medications like

Study analyzed genetic factors affecting GLP-1 drug response.
Data included nearly 28,000 participants.
Variants in GLP1 receptor gene linked to an average weight loss of 0.76 kg.
Findings suggest genetics influence treatment effectiveness and side effects.
Side effects observed included nausea and vomiting.
Research supports personalized treatment strategies in weight management.
Combination of genetic and clinical data can improve prediction of treatment outcomes.

The Medicine Maker

May 5, 2026

Pharma Supply Chains in the Crossfire

May 5, 2026
8 min

Summary
Takeaways

Pharmaceutical supply chains are facing unprecedented challenges due to a US Supreme Court ruling that limits the President's authority to impose tariffs under

Supreme Court ruling limits President's tariff powers.
Pharmaceutical companies face uncertainty in compliance and costs.
Importance of operational agility in logistics management.
Companies reassessing clinical trial locations and costs.
Bonded warehouses serve as strategic assets for product storage.

The Ophthalmologist

May 5, 2026

Surgical Confidence with Hydrus®

May 5, 2026
5 min

Summary
Takeaways

Nishani Amerasinghe, an ophthalmic surgeon, has successfully performed Hydrus® Microstent procedures for over a year. During her presentation at the European Gl

Successful Hydrus Microstent procedures have been performed for over a year.
Importance of good visualization in surgery.
Four principal stages of Hydrus implantation.
Utilization of ergonomic techniques for better surgical outcomes.
Immediate visual feedback allows for real-time corrections during surgery.
Incision techniques tailored for optimal stent delivery.
The role of the Ingenuity 3D Visualisation System in enhancing clarity during procedures.
Learning curve exists, but precision improves quickly with practice.

The Ophthalmologist

May 5, 2026

AI Boosts Diabetic Eye Care Access

May 5, 2026
3 min

Summary
Takeaways

Objective: To evaluate the impact of autonomous AI-assisted diabetic retinopathy (DR) screening on patient attendance at specialist eye care. Key Findings: Pati

Diabetic retinopathy screening is suboptimal globally, with US adherence rates as low as 20% and significant disparities in access.
A study from Johns Hopkins Medicine shows that autonomous AI can improve screening rates and access to specialist eye care.
Patients screened via AI were more likely to attend eye care specialists, especially African-American patients who are historically underserved.
Point-of-care AI screening integrates into primary care, providing immediate results and actionable referrals to enhance patient follow-up.
Improving screening alone is insufficient; downstream access to ophthalmic care is crucial for better diabetic retinopathy outcomes.

The Analytical Scientist

May 5, 2026

A Molecular Record of Repairs from a Roman Shipwreck

May 5, 2026
3 min

Summary
Takeaways
Insight Report
Quiz
Poll
Top Institutions

Objective: To analyze waterproofing residues from a 2,200-year-old Roman shipwreck to understand the vessel's repair history and the materials used. Key Finding

A molecular and pollen analysis of a Roman shipwreck revealed distinct coating batches, indicating successive repairs.
The study focused on organic hull coatings from the Ilovik–Paržine 1 wreck, discovered off Ilovik Island, Croatia.
Coatings were primarily based on conifer-derived materials, with diagnostic markers indicating heat-treated resin or wood tar.
Statistical analysis identified four to five distinct coating batches, reflecting different sourcing locations during repairs.
The research highlights the significance of waterproofing residues in understanding local shipbuilding and repair traditions.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

The Medicine Maker

May 5, 2026

This Week’s Biopharma News: EU Clears First Pertuzumab Biosimilar

May 5, 2026
5 min

Summary
Takeaways
Quiz
Clinical Scorecard
Top Institutions

Objective: To report on significant developments in biopharmaceuticals, including approvals and advancements in therapies. Key Findings: POHERDY is authorized f

The EU has approved the first pertuzumab biosimilar, POHERDY, for HER2-positive breast cancer, expanding treatment options in Europe.
POHERDY's approval is based on comprehensive data demonstrating high similarity to Roche's PERJETA, including efficacy and safety.
Genexine's GX-BP1 shows strong preclinical activity in resistant cancer models, achieving up to 96% tumor growth inhibition in combination therapies.
NICE has recommended rozanolixizumab as the first treatment for uncontrolled generalized myasthenia gravis in adults, available through interim funding.
Ecolab has opened a Bioprocessing Applications Lab in Korea to support biopharmaceutical manufacturers in optimizing purification workflows.

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

The Pathologist

May 5, 2026

Weight-loss Drug Response Varies, But Why?

May 5, 2026
2 min

Summary
Insight Report
Quiz
Top Institutions

Objective: To investigate how genetic differences influence the response to GLP-1-based weight-loss drugs and the risk of side effects. Key Findings: Identifica

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

The Medicine Maker

May 5, 2026

Pharma Supply Chains in the Crossfire

May 5, 2026
8 min

Summary
Takeaways
Insight Report
Quiz
Clinical Scorecard

Objective: To explore the urgent impact of recent US Supreme Court rulings and geopolitical tensions on pharmaceutical supply chains. Key Findings: The Supreme

The US Supreme Court ruled that the President cannot impose tariffs under the International Emergency Economic Powers Act, complicating compliance for pharma companies.
Pharmaceutical companies face rising costs and delays in clinical trials due to geopolitical tensions and existing tariffs, impacting their operational strategies.
Organizations must conduct granular audits to assess the impact of overturned tariffs and existing duties, while seeking exemptions to mitigate financial losses.
Companies are reevaluating their manufacturing locations and clinical trial plans due to policy volatility and uncertain cost forecasts.
The ongoing conflict in the Middle East is expected to increase costs and supply shortages across the pharmaceutical industry, affecting logistics and planning.

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

The Ophthalmologist

May 5, 2026

Surgical Confidence with Hydrus®

May 5, 2026
5 min

Summary
Quiz
Clinical Scorecard
Top Institutions

Objective: To share insights and techniques for successful Hydrus® Microstent implantation. Key Findings: Good visualization is critical for successful Hydrus i

Get a concise, at-a-glance scorecard that distills clinical guidelines into key recommendations, patient insights, and treatment considerations.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

Frontiers In Neurology

May 5, 2026

The interictal symptom burden in vestibular migraine—a condition in need of recognition

H. M. Rust
A. Palla
May 5, 2026

Summary
Takeaways
Quiz
Poll
Top Institutions

Objective: To summarize current evidence on persistent interictal manifestations of vestibular migraine (VM) and discuss their implications for diagnosis and cl

Vestibular migraine (VM) includes persistent vestibular symptoms during the interictal phase, extending beyond discrete migraine attacks.
Common interictal symptoms of VM include head-motion intolerance, visually induced dizziness, and increased motion sickness susceptibility.
Altered central vestibular sensory and oculomotor networks, rather than peripheral vestibular disorders, underlie interictal symptoms in VM.
Longitudinal studies show that interictal vestibular symptoms may increase over time, even as the frequency of VM attacks decreases.
The review proposes preliminary diagnostic criteria for chronic vestibular migraine based on symptom frequency and persistence.

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Share your perspective with a quick, clinically relevant poll that captures real-world insights and clinician sentiment.

Discover top institutions in a clinical specialty, with data-driven rankings and profiles highlighting their research, clinical strengths, and leadership.

View Institutions

Advertisement

Advertisement

Advertisement

About
Privacy Policy

Follow Us

Author/Creator Name

[Credentials]

[Current title or role]

Affiliations: [Institution, organization]

Specialties: Oncology Hematology

View Full Profile

Contributions:

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

[brand name]

Content Title Goes Here and it Will Get Clamped at Two line

[author name] July 23, 2025 5 min

Show all